Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4123, doi. 10.1038/onc.2013.380
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2014 AND VI 33 AND IP 32
Results: 9
1
2
The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4185, doi. 10.1038/onc.2013.388
- By:
- Publication type:
- Article
3
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4173, doi. 10.1038/onc.2013.471
- By:
- Publication type:
- Article
4
The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4107, doi. 10.1038/onc.2013.379
- By:
- Publication type:
- Article
5
E2F1 drives chemotherapeutic drug resistance via ABCG2.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4164, doi. 10.1038/onc.2013.470
- By:
- Publication type:
- Article
6
EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4156, doi. 10.1038/onc.2013.397
- By:
- Publication type:
- Article
7
PTEN ablation in Ras<sup>Ha</sup>/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4132, doi. 10.1038/onc.2013.372
- By:
- Publication type:
- Article
8
A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4114, doi. 10.1038/onc.2013.376
- By:
- Publication type:
- Article
9
FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.
- Published in:
- Oncogene, 2014, v. 33, n. 32, p. 4144, doi. 10.1038/onc.2013.457
- By:
- Publication type:
- Article